BIOMAT Database Logo BIOMAT Database Logo

Systemic effects of large doses of hydrocortisone acetate and prednisolone acetate administered intra-articularly to patients with rheumatoid arthritis. 1962

M OKA, and K LAHDESMAKI

UI MeSH Term Description Entries
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D001168 Arthritis Acute or chronic inflammation of JOINTS. Oligoarthritis,Polyarthritis,Arthritides,Oligoarthritides,Polyarthritides
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

M OKA, and K LAHDESMAKI
Effects in rheumatoid arthritis of hydrocortisone and cortisone injected intra-articularly.
December 1952, A.M.A. archives of internal medicine,
M OKA, and K LAHDESMAKI
Disposition of intra-articularly injected hydrocortisone acetate, hydrocortisone free alcohol and cortisone acetate in arthritis.
July 1955, Experientia,
M OKA, and K LAHDESMAKI
The injection of concentrated prednisolone trimethylacetate intra-articularly in rheumatoid arthritis.
December 1959, Proceedings of the Royal Society of Medicine,
M OKA, and K LAHDESMAKI
Intra-articular hydrocortisone acetate in rheumatoid arthritis.
August 1952, Lancet (London, England),
M OKA, and K LAHDESMAKI
Disposition of intra-articularly injected hydrocortisone acetate, hydrocortisone and cortisone acetate in arthritis. I. Concentrations in synovial fluid and cells.
July 1954, The Journal of clinical endocrinology and metabolism,
M OKA, and K LAHDESMAKI
Intra-articular therapy in rheumatoid arthritis: comparison of hydrocortisone tertiary butyl acetate and hydrocortisone acetate.
September 1958, Lancet (London, England),
M OKA, and K LAHDESMAKI
Effectiveness of methylprednisolone and prednisolone tertiary-butylacetate intra-articularly in rheumatoid arthritis: a comparative study.
October 1960, Canadian Medical Association journal,
M OKA, and K LAHDESMAKI
Hydrocortisone and prednisolone in rheumatoid arthritis.
April 1958, The Medical journal of Australia,
M OKA, and K LAHDESMAKI
Effect of intra-articularly injected hydrocortisone acetate on the polysaccharide complex.
January 1958, Annales medicinae experimentalis et biologiae Fenniae,
M OKA, and K LAHDESMAKI
Hydrocortisone versus prednisolone in rheumatoid arthritis.
July 1956, Lancet (London, England),
Copied contents to your clipboard!